Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2005-005723-34Phase 4Active
Phase 4 trial of aspirin in diabetes mellitus type 1 (T1D) (2 arms), sponsored by Department of Medicine. Primary endpoint: Fibrin gel porosity. Started Dec 2005; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2005-005723-34.